24 November 2016 - Deborah Wilkes
Archived
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is consulting on a proposal to switch Bayer's Nasonex (mometasone furoate) nasal spray from prescription-to-OTC status.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.